News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Murray Mark Christopher
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/17/2023 |
4
| Murray Mark Christopher (SVP - Acetyls) has filed a Form 4 on Celanese Corp|
Txns:
| Paid exercise price by delivering 470 shares
@ $122.13, valued at
$57.4k
|
|
| 05/15/2023 |
4
| Murray Mark Christopher (SVP - Acetyls) has filed a Form 4 on Celanese Corp|
Txns:
| Bought 1,008 shares
@ $101.689, valued at
$102.5k
|
|
| 03/02/2023 |
4
| Murray Mark Christopher (SVP - Acetyls) has filed a Form 4 on Celanese Corp|
Txns:
| Bought 1,200 shares
@ $117.15, valued at
$140.6k
Granted 8,044 options to buy
@ $116.93, valued at
$940.6k
|
|
| 11/17/2022 |
3
| Murray Mark Christopher (VP - Bus. Strat & Development) has filed a Form 3 on Celanese Corp |
| 01/18/2022 |
4
| Murray Mark Christopher (EVP, Biomaterials & AT) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 918 shares
@ $37.5, valued at
$34.4k
|
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Murray Mark Christopher (EVP, Biomaterials & AT) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 12,376 shares
@ $0
Granted 120,107 options to buy
@ $18.18, valued at
$2.2M
|
|
| 01/15/2020 |
3
| Murray Mark Christopher (EVP, Biomaterials & AT) has filed a Form 3 on Avantor, Inc. |
|
|